Menu

 

All Sites Sorted » Health Beauty and Fitness » Medicine


 


Sponsored

 

Latest News

Synergy Pharmaceuticals Surges as Investors Await Data
Synergy Pharmaceuticals Inc. (SGYP) , a developer of drugs for gastrointestinal disorders, increased the most in a year on investor optimism that its experimental treatment for irritable bowel syndrome may have helped patients in a study. Thu, 24 Apr 2014 11:14:14 -0700

Salix Pharmaceuticals Announces 1Q2014 Financial Results Conference Call and Webcast
Salix Pharmaceuticals, Ltd. today announced that the Company will report first quarter 2014 financial results following the close of the U.S. financial markets on Thu Thu, 24 Apr 2014 04:00:00 -0700

GW Pharmaceuticals plc (GWPH) Soars: Stock Up 13.9%
GW Pharmaceuticals plc was a big mover last session, as its shares rose nearly 14% on the day. Wed, 23 Apr 2014 22:18:24 -0700

Agios Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Agios Pharmaceuticals, Inc. today announced the pricing of its underwritten public offering of 2,000,000 shares of its common stock at a public offering price of $44.00 per share, before underwriting discounts. Wed, 23 Apr 2014 15:56:00 -0700

Ligand’s Partner Spectrum Pharmaceuticals Reports Captisol-Enabled Melphalan Meets Primary Endpoint in Pivotal Trial
Ligand Pharmaceuticals Incorporated announces that its Captisol-enabled™ Melphalan development and commercial partner Spectrum Wed, 23 Apr 2014 04:10:00 -0700

Spectrum Pharmaceuticals’ Pivotal Trial of Captisol-Enabled™ (Propylene Glycol-Free) Melphalan Meets Primary Endpoint
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, Wed, 23 Apr 2014 04:00:00 -0700

Kala Pharmaceuticals Announces $22.5 Million Series B Financing
Kala Pharmaceuticals, Inc., a leading developer of innovative ophthalmic products based on the company’s proprietary Mucus Penetrating Particle platform technology, today announced it has completed a $22.5 million Series B financing. Wed, 23 Apr 2014 03:30:00 -0700

Valeant Pharmaceuticals International (VRX) Soars: Stock Up 7.5%
Valeant Pharmaceuticals International, Inc. was a big mover last session, as its shares rose nearly 8% on the day. Tue, 22 Apr 2014 22:54:28 -0700

Cubist Pharmaceuticals Reports First Quarter 2014 Financial Results
Cubist Pharmaceuticals, Inc. today announced results for the first quarter ended March 31, 2014. The Company will host a conference call and webcast today at 5:00 p.m. Tue, 22 Apr 2014 13:00:00 -0700

FORUM Pharmaceuticals Inc. Appoints Todd Shegog As Chief Financial Officer
FORUM Pharmaceuticals Inc. , a biotechnology company singularly focused on the development and delivery of innovative medicines to treat challenging brain diseases, today announced the appointment of Todd Shegog as Senior Vice President and Chief Financial Officer. Tue, 22 Apr 2014 05:30:00 -0700

Website Directory Sort by: Hits | Alphabetical

Features

Top 5 Web Hosts
(Largest)


Top 5 Favorite Web Hosts

   1. HostGator
   2. LunarPages
   3. Yahoo! Web Hosting
   4. HostMonster
   5. BlueHost